Premium
Doxycycline Significantly Enhances Induction of iPSCs to Endoderm by Enhancing Survival via AKT Phosphorylation
Author(s) -
Peaslee Caitlin,
Su Tao,
EstevaFont Cristina,
Duwaerts Caroline,
Liu Ke,
MunozHowell Antonio,
Medina Marisa,
Maher Jacquelyn,
Mattis Aras
Publication year - 2021
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2021.35.s1.04134
Subject(s) - protein kinase b , doxycycline , phosphorylation , endoderm , pharmacology , chemistry , microbiology and biotechnology , medicine , biology , biochemistry , embryonic stem cell , antibiotics , gene
Induced pluripotent stem cells (iPSCs) provide an important tool for the generation of patient‐derived cells including hepatocyte‐like cells via developmental cues through an endoderm intermediate. However, most iPSC lines fail to differentiate into endoderm, with induction resulting in apoptosis. To address this issue, we built upon published methods to develop an improved protocol. We discovered that doxycycline dramatically enhances the iPSC to endoderm differentiation efficiency by inhibiting apoptosis and promoting proliferation via the AKT (protein kinase B) pathway. We tested this new protocol in more than 70 iPSC lines with consistent formation of complete sheets of endoderm in 90%. Endoderm generated by our method achieves similar transcriptomic profiles, positive immunohistochemistry for endoderm protein markers, and the ability to be further differentiated. Furthermore this method achieves a four‐fold increase in endoderm cell number and will accelerate studies of human diseases in vitro and facilitate the expansion of iPSC‐derived cells for transplantation studies.